blood cancer cure cost

IIT-B startup ImmunoACT’s “affordable” blood cancer therapy gets regulatory approval – a first for India’s CAR-T cell therapy – Times of India

[ad_1] An IIT Bombay incubated company, ImmunoACT, has been granted approval by Indian drug regulator Central Drugs Standard Control Organization…